Key facts
- Qidni Labs’s last known valuation is $22.5M (Aug 2025).
- It has raised $8.5M; the latest was Later Stage VC ($5.0M) in Aug 2025.
- Notable investors include SOSV, Endless Frontier Labs, IndieBio, MaRS Discovery District, Neman Ventures — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Qidni Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Qidni Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Qidni Labs
Developer of dialysis technologies and devices designed to make dialysis accessible and sustainable for patients with kidney failure worldwide. The company offers a portable dialysis system that is nearly waterless and battery-powered with cloud-based remote monitoring of treatment and helps remove uremic toxins and other solutes from large volumes of whole blood, enabling patients to remove all barriers in the way patients access treatment.
- Sector
- Healthcare
- HQ
- Buffalo, NY, United States
- Founded
- 2014
- Employees
- 9
- Website
- qidni.life/
- Ownership
- Privately Held (backing)
Qidni Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qidni Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qidni Labs in its N-PORT filings yet. We sweep new filings monthly.